Real-time enrollment status for this metastatic castration resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 9:18 PM UTC
| NCT Number | NCT07719361 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration Resistant Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Flare Therapeutics Inc. |
| Last Updated on CT.gov | July 22, 2026 (21 hours ago) |
As of July 22, 2026: Clinical trial NCT07719361 is currently recruiting participants. This phase1 study for metastatic castration resistant prostate cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Flare Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07719361 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07719361 was last updated 21 hours ago (July 22, 2026). HelloStudys verifies this status automatically.